Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects. - GreenMedInfo Summary

Abstract Title:

Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects: a randomized double-blind controlled trial.

Abstract Source:

Diabetes Care. 2003 Apr;26(4):1147-52. PMID: 12663588

Abstract Author(s):

Martha Rodríguez-Morán, Fernando Guerrero-Romero

Abstract:

OBJECTIVE:To determine whether oral magnesium supplementation (as magnesium chloride [MgCl(2)] solution) improves both insulin sensitivity and metabolic control in type 2 diabetic subjects with decreased serum magnesium levels. RESEARCH DESIGN AND METHODS: This study was a clinical randomized double-blind placebo-controlled trial. A total of 63 subjects with type 2 diabetes and decreased serum magnesium (serum magnesium levels

Article Published Date : Apr 01, 2003
Study Type : Human Study
Additional Links
Substances : Magnesium : CK(2760) : AC(366)
Diseases : Diabetes Mellitus: Type 2 : CK(11728) : AC(2489), Insulin Resistance : CK(4532) : AC(1074)
Pharmacological Actions : Hypoglycemic Agents : CK(8194) : AC(2016)

Print Options

Some features are currently member only features. If you are already a member, please login. Otherwise, click here to become a member.
  • Printer-friendly version

Key Research Topics

Substance

Magnesium

Disease

Diabetes Mellitus: Type 2
Insulin Resistance

Pharmacological Actions

Hypoglycemic Agents

Connect with GreenMedInfo

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2024 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.